RightFit
RecruitingPhase not listed

Collection of Information to Better Understand Young Onset Colorectal Cancer

Young Onset Gastrointestinal Cancer Prospective Registry

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects health information to better understand colorectal cancer, which starts in the colon or rectum, diagnosed before age 50. Researchers will compare it with colorectal cancer diagnosed later in life and use the information for current and future research. The study includes younger adults with digestive system cancer and adults age 50 or older with colorectal cancer.

The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Younger group: Ages 18–49 when agreeing to join, with digestive system cancer confirmed by tissue or cell testing.
  • Younger group giving stool samples: No known inherited colorectal cancer or other condition that raises cancer risk.
  • Younger group giving stool samples: No history of inflammatory bowel disease, which causes long-term swelling in the gut.
  • Younger group giving stool samples: No earlier diagnosis of digestive system cancer.
  • Comparison group: Age 50 or older when agreeing to join, with colorectal adenocarcinoma, a cancer of gland-forming cells, confirmed by tissue or cell testing.
  • Comparison group: No previous colorectal cancer treatment, including surgery, chemotherapy, immune-based treatment, or radiation.
  • Comparison group: No known inherited colorectal cancer or other condition that raises cancer risk.
  • Comparison group: No history of inflammatory bowel disease or earlier colorectal cancer diagnosis.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: Participant Inclusion Criteria for database and questionnaire (YOGI) * Histological or cytological diagnosis of gastrointestinal cancer * 18 - 49 years old at time of consent * No Known hereditary CRC or other cancer predisposition syndrome (stool collection cohort only) * No history of inflammatory bowel disease (stool collection cohort only) * No prior diagnosis of gastrointestinal cancer (stool collection cohort only) Participant Inclusion Criteria for database and questionnaire (Controls) * Histological or cytological diagnosis of colorectal adenocarcinoma * No previous treatment for CRC (including surgery, chemotherapy, immunotherapy or radiation) * Age 50 or older at time of consent * No Known hereditary CRC or other cancer predisposition syndrome * No history of inflammatory bowel disease * No prior diagnosis of CRC

    Study sites (8)

    NJ

    NY